학술논문
Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial
Document Type
Article
Author
Amusu, Senate; Ayuk, Leo; Bilong, Catherine; Boahen, Owusu; Camara, Makhtar; Cheick Haidara, Fadima; Coly, Daouda; Dièye, Siry; Dosoo, David; Ekedi, Melanie; Eneida Almeida Dos Santos, Irma; Kaali, Seyram; Kokogho, Afoke; Levine, Myron; Opoku, Nick; Owusu-Agyei, Seth; Pitmang, Simon; Sall, Fatima; Seydi, Moussa; Sztein, Marcelo; Tejiokem, Mathurin; Traore, Awa; Vernet, Marie-Astrid; Yawson, Abena Kunadu; Tapia, Milagritos D ; Sow, Samba O; Ndiaye, Birahim P; Mbaye, Khardiata D; Thiongane, Aliou; Ndour, Cheikh T; Mboup, Souleymane; Ake, Julie A; Keshinro, Babajide; Akintunde, Gideon A; Kinge, Thompson N; Vernet, Guy; Bigna, Jean Joel; Oguche, Stephen; Koram, Kwadwo A; Asante, Kwaku P; Hogrefe, Wayne R; Günther, Stephan; Naficy, Abdi; De Ryck, Iris; Debois, Muriel; Bourguignon, Patricia; Jongert, Erik; Ballou, William R; Koutsoukos, Marguerite; Roman, François
Source
In The Lancet Infectious Diseases June 2020 20(6):707-718
Subject
Language
ISSN
1473-3099